Outbreaks of dengue disease are constant threats to tropical and subtropical populations but range widely in severity, from mild to haemorrhagic fevers, for reasons that are still elusive. We investigated the interferon (IFN) response in infected human cell lines A549 and HepG2, using two strains (NGC and TSV01) of dengue serotype 2 (DEN2) and found that the two viruses exhibited a marked difference in inducing type I IFN response. While TSV01 infection led to activation of type I antiviral genes such as EIF2AK2 (PKR), OAS, ADAR and MX, these responses were absent in NGC-infected cells. Biochemical analysis revealed that NGC but not TSV01 suppressed STAT-1 and STAT-2 activation in response to type I IFN (α and β). However, these two strains did not differ in their response to type II IFN (γ). Although unable to suppress IFN signalling, TSV01 infection caused a weaker IFN-β induction compared with NGC, suggesting an alternative mechanism of innate immune escape. We extended our study to clinical isolates of various serotypes and found that while MY10245 (DEN2) and MY22713 (DEN4) could suppress the IFN response in a similar fashion to NGC, three other strains of dengue [EDEN167 (DEN1), MY02569 (DEN1) and MY10340 (DEN2)] were unable to suppress the IFN response, suggesting that this difference is strain-dependent but not serotype-specific. Our report indicates the existence of a strain-specific virulence factor that may impact on disease severity.
AjariyakhajornC.,
MammenM. P.Jr,
EndyT. P.,
GettayacaminM.,
NisalakA.,
NimmannityaS.,
LibratyD. H.2005; Randomized, placebo-controlled trial of nonpegylated and pegylated forms of recombinant human alpha interferon 2a for suppression of dengue virus viremia in rhesus monkeys. Antimicrob Agents Chemother 49:4508–4514[CrossRef]
AlvarezD. E.,
De Lella EzcurraA. L.,
FucitoS.,
GamarnikA. V.2005; Role of RNA structures present at the 3′UTR of dengue virus on translation, RNA synthesis, and viral replication. Virology 339:200–212[CrossRef]
BravoJ. R.,
GuzmánM. G.,
KouriG. P.1987; Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS).. Trans R Soc Trop Med Hyg 81:816–820[CrossRef]
ChengG.,
ZhongJ.,
ChisariF. V.2006; Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 103:8499–8504[CrossRef]
DiamondM. S.,
RobertsT. G.,
EdgilD.,
LuB.,
ErnstJ.,
HarrisE.2000; Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74:4957–4966[CrossRef]
FagbamiA. H.,
MataikaJ. U.,
ShresthaM.,
GublerD. J.1995; Dengue type 1 epidemic with haemorrhagic manifestations in Fiji, 1989–90. Bull World Health Organ 73:291–297
GublerD. J.,
ReedD.,
RosenL.,
HitchcockJ. R.Jr1978; Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg 27:581–589
GublerD. J.,
SuharyonoW.,
LubisI.,
EramS.,
GunarsoS.1981; Epidemic dengue 3 in central Java, associated with low viremia in man. Am J Trop Med Hyg 30:1094–1099
KubotaT.,
YokosawaN.,
YokotaS.,
FujiiN.2002; Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex. J Virol 76:12676–12682[CrossRef]
LeitmeyerK. C.,
VaughnD. W.,
WattsD. M.,
SalasR.,
VillalobosI.,
de Chacon,
RamosC.,
Rico-HesseR.1999; Dengue virus structural differences that correlate with pathogenesis. J Virol 73:4738–4747
LuoX. M.,
RossA. C.2005; Physiological and receptor-selective retinoids modulate interferon γ signaling by increasing the expression, nuclear localization, and functional activity of Interferon regulatory factor-1. J Biol Chem 280:36228–36236[CrossRef]
MesserW. B.,
VitaranaU. T.,
SivananthanK.,
ElvtigalaJ.,
PreethimalaL. D.,
RameshR.,
WithanaN.,
GublerD. J.,
De SilvaA. M.2002; Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg 66:765–773
MesserW. B.,
GublerD. J.,
HarrisE.,
SivananthanK.,
de SilvaA. M.2003; Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 9:800–809[CrossRef]
MillerS.,
SparacioS.,
BartenschlagerR.2006; Subcellular localization and membrane topology of the Dengue virus type 2 Non-structural protein 4B. J Biol Chem 281:8854–8863[CrossRef]
Munoz-JordanJ. L.,
Sanchez-BurgosG. G.,
Laurent-RolleM.,
Garcia-SastreA.2003; Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 100:14333–14338[CrossRef]
Munoz-JordanJ. L.,
Laurent-RolleM.,
AshourJ.,
Martinez-SobridoL.,
AshokM.,
LipkinW. I.,
Garcia-SastreA.2005; Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79:8004–8013[CrossRef]
PandeyB. D.,
IgarashiA.2000; Severity-related molecular differences among nineteen strains of dengue type 2 viruses. Microbiol Immunol 44:179–188[CrossRef]
Rico-HesseR.,
HarrisonL. M.,
SalasR. A.,
TovarD.,
NisalakA.,
RamosC.,
BoshellJ.,
de MesaM. T.,
NogueiraR. M.,
da RosaA. T.1997; Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230:244–251[CrossRef]
SethR. B.,
SunL.,
EaC. K.,
ChenZ. J.2005; Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF- κ B and IRF 3. Cell 122:669–682[CrossRef]
ShawM. L.,
Garcia-SastreA.,
PaleseP.,
BaslerC. F.2004; Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol 78:5633–5641[CrossRef]
ShrestaS.,
KyleJ. L.,
SniderH. M.,
BasavapatnaM.,
BeattyP. R.,
HarrisE.2004; Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol 78:2701–2710[CrossRef]
WattsD. M.,
PorterK. R.,
PutvatanaP.,
VasquezB.,
CalampaC.,
HayesC. G.,
HalsteadS. B.1999; Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 354:1431–1434[CrossRef]